Patents by Inventor Carine Blanchard

Carine Blanchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139264
    Abstract: The present invention relates to a composition for use in the prevention of respiratory allergy, in particular allergic rhinitis, dust mite allergy and/or asthma in toddlers. The invention also provides a kit comprising a combination of at least one polyphenol and at least one probiotic selected from the group consisting of Lactobacillus paracasei and Lactococcus lactis in one or more containers.
    Type: Application
    Filed: February 16, 2022
    Publication date: May 2, 2024
    Inventors: CARINE BLANCHARD, SEBASTIEN HOLVOET
  • Publication number: 20240122998
    Abstract: The present invention relates to a composition for use in the prevention of respiratory allergy, in particular allergic rhinitis, dust mite allergy and/or asthma. The invention also provides a kit comprising a combination of at least one polyphenol and at least one Bifidobacterium longum in one or more containers.
    Type: Application
    Filed: February 16, 2022
    Publication date: April 18, 2024
    Inventors: CARINE BLANCHARD, FRANCINE LENFANT, ULRIKE REYMONDIN, GAELLE MARIE LAURE SCHLUP-OLLIVIER, JOYDEEP RAY, SEBASTIEN HOLVOET, CHRISTOPHE BARDE
  • Publication number: 20240009216
    Abstract: A nutritional composition comprising the human milk oligosaccharides (HMOs) 2?-fucosyllactose (2FL), 3?-fucosyl-lactose (3FL), 3?-sialyllactose (3SL), and lacto-N-neotetraose (LNnT). The nutritional composition is useful for treating or preventing disorders associated with an above-normal number of granulocytes in a tissue. For example, the combinations may have utility in preventing or treating eosinophilic gastrointestinal diseases.
    Type: Application
    Filed: November 9, 2021
    Publication date: January 11, 2024
    Inventors: CARINE BLANCHARD, CHEONG KWET CHOY KWONG CHUNG, SEBASTIEN HOLVOET, DOMINIQUE SANDRA DONNICOLA
  • Publication number: 20230381211
    Abstract: A nutritional composition comprising the human milk oligosaccharides (HMOs) 2?-fucosyllactose (2FL), 3?-fucosyl-lactose (3FL), 3-sialyllactose (SSL), and lacto-N-neotetraose (LNnT). The nutritional composition is useful for inducing tolerance to an allergen, and/or speeding up outgrowth of an allergy, and/or treating or reducing the risk of an interleukin IL-10 mediated disease.
    Type: Application
    Filed: October 7, 2021
    Publication date: November 30, 2023
    Inventors: CARINE BLANCHARD, SEBASTIEN HOLVOET, DOMINIQUE SANDRA DONNICOLA, CHEONG KWET CHOY KWONG CHUNG
  • Publication number: 20230115476
    Abstract: Use of a compound having the formula (1) (2) (3) (4) or combinations thereof, for providing a source of butyrate with improved organoleptic properties wherein R1, R2, R3, R4, R5 and R6 are independently a long chain fatty acid having between 16 and 20 carbons for use in recovery from antibiotic mediated gut microbiota disturbance and/or preventing and/or treating gastrointestinal infections.
    Type: Application
    Filed: December 4, 2020
    Publication date: April 13, 2023
    Inventors: ELIZABETH FORBES-BLOM, AMAURY PATIN, CARINE BLANCHARD, MARIO NOTI
  • Publication number: 20230102803
    Abstract: Use of a compound having the formula (1) (2) (3) (4) or, or combinations thereof, for providing a source of butyrate with improved organoleptic properties wherein R1, R2, R3, R4, R5 and R6 are independently a long chain fatty acid having between 16 and 20 carbons for use in promoting immune response and/or preventing and/or treating bacterial and/or viral infections.
    Type: Application
    Filed: December 4, 2020
    Publication date: March 30, 2023
    Inventors: ELIZABETH FORBES-BLOM, AMAURY PATIN, CARINE BLANCHARD, MARIO NOTI
  • Publication number: 20230098752
    Abstract: The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.
    Type: Application
    Filed: November 29, 2022
    Publication date: March 30, 2023
    Inventors: Carine Blanchard, Sebastien Holvoet, Rinat Ran-Ressler, Martinas Kuslys
  • Publication number: 20230026618
    Abstract: An infant formula for use in preventing or reducing the occurrence of allergic sensitisation in an infant, wherein the infant formula comprises 0.8-2.5 g/L 2?-fucosyllactose (2?FL) and/or 0.05-0.2 g/L lacto-N-neotetraose (LNnT).
    Type: Application
    Filed: December 28, 2020
    Publication date: January 26, 2023
    Inventors: CARINE BLANCHARD, SEBASTIEN HOLVOET
  • Patent number: 11541031
    Abstract: The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: January 3, 2023
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet, Rinat Ran-Ressler, Martinas Kuslys
  • Patent number: 11382891
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosemarinic acid, ellagic acid, and chlorogenic acid, can be used in the treatment or prevention of eosinophilic esophagitis.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: July 12, 2022
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet
  • Publication number: 20220079908
    Abstract: A compound having the formula or combinations thereof, for use in the treatment or prevention of an allergic disorder, wherein R1, R2, R3, R4, R5 and R6 are independently, a long chain fatty acid having between 16 and 20 carbons.
    Type: Application
    Filed: December 19, 2019
    Publication date: March 17, 2022
    Inventors: Carine Blanchard, Tristan Bourdeau, Frederic Destaillats, Elizabeth Forbes-Blom, Sophle Nutten, Heiko Oerting, Amaury Patin
  • Publication number: 20220071942
    Abstract: A composition comprising a compound having the formula (1), (2), (3), (4) or combinations thereof, wherein n1, n2, n3, n4, n5 and n6 are independently 4 to 10.
    Type: Application
    Filed: December 17, 2019
    Publication date: March 10, 2022
    Inventors: Carine Blanchard, Bernard Cuenoud, Frederic Destaillats, Elizbeth Forbes-Blom, Heiko Oertling, Amaury Patin
  • Publication number: 20220062161
    Abstract: The present invention relates to the use of a milk whey protein hydrolysate for preventing or treating transepidermal water loss (TEWL) and/or TEWL-associated disorders or/and enhancing skin barrier function in young and adult mammals. The protein hydrolysate may be used in the prevention or treatment of TEWL-associated disorders, such as atopic dermatitis, dry or reactive skin or skin dehydration. It may also be used in the cosmetic use of improving skin appearance.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 3, 2022
    Inventors: Carine Blanchard, Sebastien Holvoet
  • Patent number: 11229659
    Abstract: The present invention relates to a nutritional composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising at least one N-acetylated oligosaccharide, one galacto-oligosaccharide and one sialylated oligosaccharide for use in preventing and/or treating allergy symptoms in an infant or a young child, by increasing SFCA production, in particular colonic acetate, propionate and/or butyrate, in said infant or young children.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: January 25, 2022
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Chiara Nembrini
  • Patent number: 11224651
    Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in preventing and/or treating allergy symptoms in an infant or a young child, by increasing propionate production, in said infant or young children.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: January 18, 2022
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Chiara Nembrini
  • Patent number: 11096410
    Abstract: The invention discloses a composition comprising oligosaccharide, for use in the prevention and/or treatment of skin conditions and/or skin diseases by increasing SCFA, in particular colonic propionate and butyrate. Said skin disease is in particular atopic dermatitis.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: August 24, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Chiara Nembrini
  • Publication number: 20210038554
    Abstract: Use of a compound having the formula (1), (2), (3), or (4) or combinations thereof, for providing a source of butyrate with improved organoleptic properties wherein R1, R2, R3, R4, R5 and R6 are independently a long chain fatty acid having between 16 and 20 carbons.
    Type: Application
    Filed: May 21, 2019
    Publication date: February 11, 2021
    Inventors: Carine Blanchard, Frederic Destaillats, Elizabeth Forbes-Blom, Heiko Oertling, Amaury Patin, Timothy James Wooster
  • Patent number: 10751308
    Abstract: The present invention relates to the use in a pregnant or lactating woman of SFCA ingredient, SCFA originating ingredients or mixtures thereof for preventing and/or treating trans epidermal water loss (TEWL) and/or TEWL-associated disorders and/or enhance skin barrier function in the off-spring or breast-fed infant.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: August 25, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Chiara Nembrini
  • Publication number: 20200222363
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosemarinic acid, ellagic acid, and chlorogenic acid, can be used in the treatment or prevention of eosinophilic esophagitis.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 16, 2020
    Inventors: Carine Blanchard, Sebastien Holvoet
  • Patent number: 10548873
    Abstract: Plant phenols, in particular, plant phenolic acids, like rosmarinic acid, ellagic acid, and chlorogenic acid, are used in the treatment or prevention of eosinophilic esophagitis.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: February 4, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Carine Blanchard, Sebastien Holvoet